Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New treatment approach may help patients with eczema

20.06.2003


For patients with eczema, applying fluticasone propionate cream twice a week, alongside daily emollient treatment, significantly reduces the risk of relapse, say researchers in this week’s BMJ.



The study involved 376 patients with moderate to severe eczema from 39 dermatology clinics in six countries. All patients were experiencing a ’flare’ of their condition.

Patients applied fluticasone propionate (cream or ointment; once or twice daily) for four weeks to stabilise their condition. A total of 295 patients whose eczema was brought under control then entered a maintenance phase, applying fluticasone propionate or a placebo (emollient alone) twice weekly for up to 16 weeks. All patients continued to apply emollient on a daily basis with a bath oil as needed.


After 16 weeks in the maintenance phase, the disease remained under control in 133 patients (87 using fluticasone propionate and 46 using emollient alone). Average time to relapse was six weeks for emollient alone compared with more than 16 weeks for fluticasone propionate.

Patients who applied fluticasone propionate cream were six times less likely to have a relapse than patients applying emollient alone. The groups showed no differences in adverse events.

Surprisingly, this course of treatment also addresses concerns about long term exposure to steroids because, by producing longer remission periods, it should reduce the need for intensive treatment, as is often required to control flares, say the authors.

Whether or not this maintenance strategy can be applied to other topical corticosteroids of lower potency remains to be established, they conclude.

Contact: Emma Dickinson, edickinson@bmj.com

Emma Dickinson | EurekAlert!
Further information:
http://www.bmj.com

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>